News tagged with national cancer institute
Drugs to treat anemia in cancer patients linked to thromboembolism
Nov 10, 2009 |
2.5 / 5 (2) |
1
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., ...
Bladder cancer risks increase over time for smokers
Nov 16, 2009 |
5 / 5 (1) |
1
Risk of bladder cancer for smokers has increased since the mid-1990s, with a risk progressively increasing to a level five times higher among current smokers in New Hampshire than that among nonsmokers in 2001-2004, according ...
Higher incidence of thyroid cancer in volcanic area of Sicily
Nov 05, 2009 |
not rated yet |
0
People living in volcanic areas may be at a higher risk for thyroid cancer, according to a new study published online November 5 in the Journal of the National Cancer Institute.
Age-specific evaluation of HPV DNA testing vs. cytology screening
Nov 10, 2009 |
not rated yet |
0
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of th ...
Detecting overall survival benefit derived from progression-free survival
Nov 10, 2009 |
not rated yet |
0
Overall survival (OS) may be a reasonable primary endpoint when the median survival postprogession (SSP) is less than 6 months, but it is too high a hurdle when SPP is longer than 12 months, according to a new study published ...
Antitumor activity of nutlin-3 in neuroblastoma with wild-type p53
Nov 10, 2009 |
not rated yet |
0
The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online November 10 in the Journal of the National Cancer In ...
Cancer patients and doctors report drug side effects differently
Nov 17, 2009 |
not rated yet |
0
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, ...
Estrogen receptor-alpha, breast cancer patients and tamoxifen response
Nov 25, 2009 |
not rated yet |
0
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...
Long-term testicular cancer survivors at high risk for neurological side effects
Nov 25, 2009 |
not rated yet |
0
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...
